Showing results (361-370 of 415) with videos related to
Sort By:
Pageof 42
British Journal of Clinical Pharmacology|June 27, 2006
Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinideWei Zhang, Yi-Jing He, Chun-Ting Han, et al.Acta Pharmacologica Sinica|March 7, 2017
Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancerWei-Jing Gong, Jing-Bo Peng, Ji-Ye Yin, et al.Clinical and Experimental Pharmacology & Physiology|June 3, 2011
NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitusFei-Feng Sheng, Xing-Ping Dai, Jian Qu, et al.Clinical Epigenetics|May 7, 2015
Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology resultsYu-Ligh Liou, Yu Zhang, Yingzi Liu, et al.Clinical Pharmacology and Therapeutics|March 6, 2004
St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazoleLian-Sheng Wang, Gan Zhou, Bing Zhu, et al.European Journal of Clinical Pharmacology|January 28, 2009
Effects of allicin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypesLi-Jun Yang, Lan Fan, Zhao-Qian Liu, et al.Oncotarget|September 23, 2016
COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic valueYuan-Feng Gao, Xiao-Yuan Mao, Tao Zhu, et al.Clinical Therapeutics|July 12, 2014
Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomitingHui He, Ji-Ye Yin, Ya-Jing Xu, et al.Clinical and Experimental Pharmacology & Physiology|April 2, 2014
Association of HMGB1 and HMGB2 genetic polymorphisms with lung cancer chemotherapy responseYing Wang, Xiang-Ping Li, Ji-Ye Yin, et al.Journal of Clinical Pharmacology|May 18, 2004
The influence of St John's Wort on CYP2C19 activity with respect to genotypeLian-Sheng Wang, Bing Zhu, A M Abd El-Aty, et al.Pageof 42